Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | GALR3 | O60755 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22557953 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL22557955 | 0.77 | TP53 (0.33) | — | |
| SCHEMBL509444 | 0.77 | TSHR (0.41) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL707326 | 0.77 | TSHR (0.41) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL7143131 | 0.76 | TSHR (0.46) | TSHRALDH1A1 | |
| SCHEMBL1963691 | 0.76 | TSHR (0.46) | TSHRALDH1A1 | |
| SCHEMBL7114518 | 0.75 | — | — | |
| SCHEMBL475860 | 0.74 | — | — | |
| SCHEMBL3237373 | 0.74 | LMNA (0.33) | TSHRCHRM2CHRM4CHRM1MAPT | |
| SCHEMBL476054 | 0.74 | TSHR (0.39) | TSHRALDH1A1CHRM2CHRM4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8148446-B2 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | SIGMAKALON B.V. (NL) | 2012-04-03 | — | — | US | claimed |
| US-20100249298-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | GILLARD MICHEL | 2010-09-30 | — | — | US | claimed |
| US-20070161722-A1 | Silyl Esters, Their Use in Binder Systems and Paint Compositions and a Process for Production Thereof | SIGMA COATINGS B.V. (NL) | 2007-07-12 | — | — | US | claimed |
| EP-1620514-A2 | SILYL ESTERS, THEIR USE IN BINDER SYSTEMS AND PAINT COMPOSITIONS AND A PROCESS OF PRODUCTION THEREOF | SigmaKalon B.V. (NL) | 2006-02-01 | — | — | EP | claimed |
| EP-1606329-A1 | A PROCESS FOR THE PRODUCTION OF ACID GROUP CONTAINING POLYMER RESIN | SigmaKalon B.V. (NL) | 2005-12-21 | — | — | EP | claimed |
| EP-1606338-A1 | A PROCESS FOR THE PROTECTION OF ACID GROUPS IN POLYMERS | SigmaKalon B.V. (NL) | 2005-12-21 | — | — | EP | claimed |
| US-20050222446-A1 | Process for the production of hydrocarbyl silyl carboxylate compounds | SIGMA COATINGS B.V. (NL) | 2005-10-06 | — | — | US | claimed |
| WO-2004099326-A2 | SILYL ESTERS, THEIR USE IN BINDER SYSTEMS AND PAINT COMPOSITIONS AND A PROCESS OF PRODUCTION THEREOF | SIGMAKALON B.V. (NL) | 2004-11-18 | — | — | WO | claimed |
| EP-1475415-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | SigmaKalon Services B.V. (NL) | 2004-11-10 | — | — | EP | claimed |
| WO-2004085518-A1 | A PROCESS FOR THE PROTECTION OF ACID GROUPS IN POLYMERS | SIGMAKALON B.V. (NL) | 2004-10-07 | — | — | WO | claimed |
| WO-2004085502-A1 | A PROCESS FOR THE PRODUCTION OF ACID GROUP CONTAINING POLYMER RESIN | SIGMAKALON B.V. (NL) | 2004-10-07 | — | — | WO | claimed |
| EP-1462472-A1 | A process for the protection of acid groups in polymers | Sigma Kalon Services B.V. (NL) | 2004-09-29 | — | — | EP | claimed |
| EP-1462467-A1 | A process for the production of silyl group containing polymer resin | Sigma Kalon Services B.V. (NL) | 2004-09-29 | — | — | EP | claimed |
| US-20260078130-A1 | NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF | SIRONAX LTD (KY) | 2026-03-19 | — | — | US | disclosed |
| EP-4590674-A1 | NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd (KY) | 2025-07-30 | — | — | EP | disclosed |
| EP-4126335-A1 | ANTIFOULING COATING COMPOSITION | Jotun A/S (NO) | 2023-02-08 | — | — | EP | disclosed |
| EP-1378514-A1 | Process for the preparation of acyloxysilanes | SigmaKalon Group B.V. (NL) | 2004-01-07 | — | — | EP | disclosed |
| EP-1359166-A1 | OLEFIN POLYMERIZATION CATALYST, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, METHOD OF STORING THESE, AND PROCESS FOR PRODUCING OLEFIN POLYMER | Sunallomer Ltd (JP) | 2003-11-05 | — | — | EP | disclosed |
| WO-2003080747-A1 | FILM-FORMING POLYMER AND ANTIFOULING PAINT | JOTUN AS (NO) | 2003-10-02 | — | — | WO | disclosed |
| WO-2003027124-A1 | PROCESS FOR THE PREPARATION OF ORGANOSILYLATED CARBOXYLATE MONOMERS, AND THEIR USE IN ANTIFOULING COATINGS | SIGMA COATINGS B.V. (NL) | 2003-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078130-A1 | NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF | NAMPT, NNMT, SARM1 | TSHR 363/4885ALDH1A1 2719/4885CHRM2 564/4885 |
| US-20100249298-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | LCT, PCMT1, TST | TSHR 4814/4885ALDH1A1 2426/4885CHRM2 3289/4885 |
| US-20050222446-A1 | Process for the production of hydrocarbyl silyl carboxylate compounds | FTO, SUCLG2, ALKBH3 | TSHR 4796/4885ALDH1A1 212/4885CHRM2 1077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.